Episodes 46-60 of 237
Case Consult: Treatment Options for an Unresectable HCC Patient Who Has Esophageal Varices
MinuteCE®Case Consult: Treatment Options for an Unresectable HCC Patient Who Has Esophageal Varices
Enhancing Outcomes in Unresectable HCC Through Integrated Multidisciplinary Care Models
MinuteCE®Enhancing Outcomes in Unresectable HCC Through Integrated Multidisciplinary Care Models
Managing Adverse Events Associated With ICI Combinations in Patients With Unresectable HCC
MinuteCE®Managing Adverse Events Associated With ICI Combinations in Patients With Unresectable HCC
Selecting the Optimal ICI Partner for First-Line Treatment of Unresectable HCC: CTLA-4 vs VEGFInhibitors
MinuteCE®Selecting the Optimal ICI Partner for First-Line Treatment of Unresectable HCC: CTLA-4 vs VEGFInhibitors
Empowering Treatment Choice: The Essential Role of Shared Decision-Making in Unresectable HCC
MinuteCE®Empowering Treatment Choice: The Essential Role of Shared Decision-Making in Unresectable HCC
Current Unmet Needs in the Field of Unresectable HCC
MinuteCE®Current Unmet Needs in the Field of Unresectable HCC
Use of ICI Combination Regimens in Patients With Intermediate-Stage HCC
MinuteCE®Use of ICI Combination Regimens in Patients With Intermediate-Stage HCC
Emerging First-Line ICI Combination Regimens in Patients With Unresectable HCC
MinuteCE®Emerging First-Line ICI Combination Regimens in Patients With Unresectable HCC
Case by Case: Optimizing Dual Immune Checkpoint Inhibitor Combination Therapies in Advanced Driver-Negative Non–Small Cell Lung Cancer
CME/CECase by Case: Optimizing Dual Immune Checkpoint Inhibitor Combination Therapies in Advanced Driver-Negative Non–Small Cell Lung Cancer
Optimizing Biomarker Testing to Guide Treatment Selection for Metastatic Colorectal Cancer
CME/CEOptimizing Biomarker Testing to Guide Treatment Selection for Metastatic Colorectal Cancer
Multiple Myeloma Care: Translating Evolving Practices to Oncology Nurses in Community Settings
CME/CE Broadcast ReplayMultiple Myeloma Care: Translating Evolving Practices to Oncology Nurses in Community Settings
Tailoring Your Perioperative Immunotherapy Approach for Resectable NSCLC
MinuteCE®Tailoring Your Perioperative Immunotherapy Approach for Resectable NSCLC
When Adjuvant Immunotherapy for Resectable NSCLC May Be the Better Approach
MinuteCE®When Adjuvant Immunotherapy for Resectable NSCLC May Be the Better Approach
Predicting Response to Neoadjuvant and Perioperative Chemoimmunotherapy
MinuteCE®Predicting Response to Neoadjuvant and Perioperative Chemoimmunotherapy
